Showing results (381-390 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|March 5, 2017
Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trialJeffrey A Jones, Tadeusz Robak, Jennifer R Brown, et al.
The Lancet. Haematology|March 19, 2017
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trialsSonali M Smith, Brandelyn N Pitcher, Sin-Ho Jung, et al.
The Lancet. Haematology|July 13, 2019
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 studyFranck Morschhauser, Steven Le Gouill, Pierre Feugier, et al.
The Lancet. Haematology|January 2, 2026
Intravenous iron for non-anaemic iron deficiency in pregnancy: a multicentre, two-arm, randomised controlled trialTayyiba Wasim, Natasha Bushra, Tahira Nasrin, et al.
The Lancet. Haematology|April 13, 2025
Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trialChristoph Male, Anthonie W A Lensing, Anthony K C Chan, et al.
The Lancet. Haematology|April 14, 2025
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trialJieyun Xia, Qian Sun, Dian Zhou, et al.
The Lancet. Haematology|April 2, 2025
A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trialJonathan A Cook, Piers E M Patten, Nicholas Peckham, et al.
The Lancet. Haematology|April 30, 2025
Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)Malgorzata Mikulska, Florian van Bömmel, Charlotte Mouliade, et al.
The Lancet. Haematology|April 30, 2025
Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trialMichael Northend, William Wilson, Kushani Ediriwickrema, et al.
The Lancet. Haematology|May 26, 2025
Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b studyRachael F Grace, Göksel Leblebisatan, Yesim Aydinok, et al.
Pageof 73